LU92736I2 - Ospémifène dans toutes les formes protégées par lebrevet de base - Google Patents
Ospémifène dans toutes les formes protégées par lebrevet de base Download PDFInfo
- Publication number
- LU92736I2 LU92736I2 LU92736C LU92736C LU92736I2 LU 92736 I2 LU92736 I2 LU 92736I2 LU 92736 C LU92736 C LU 92736C LU 92736 C LU92736 C LU 92736C LU 92736 I2 LU92736 I2 LU 92736I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- ospemifene
- baseline
- forms protected
- protected
- forms
- Prior art date
Links
- LUMKNAVTFCDUIE-VHXPQNKSSA-N ospemifene Chemical compound C1=CC(OCCO)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 LUMKNAVTFCDUIE-VHXPQNKSSA-N 0.000 title 1
- 229960003969 ospemifene Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/777,211 US8236861B2 (en) | 2004-02-13 | 2004-02-13 | Method for enhancing the bioavailablity of ospemifene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU92736I2 true LU92736I2 (fr) | 2015-08-10 |
Family
ID=34837941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU92736C LU92736I2 (fr) | 2004-02-13 | 2015-06-10 | Ospémifène dans toutes les formes protégées par lebrevet de base |
Country Status (21)
| Country | Link |
|---|---|
| US (5) | US8236861B2 (pt) |
| EP (1) | EP1713458B1 (pt) |
| JP (2) | JP5577011B2 (pt) |
| CN (1) | CN1925847A (pt) |
| AT (1) | ATE387910T1 (pt) |
| AU (1) | AU2005211958B2 (pt) |
| BR (1) | BRPI0507661A (pt) |
| CA (1) | CA2556089C (pt) |
| CY (2) | CY1111014T1 (pt) |
| DE (1) | DE602005005165T2 (pt) |
| DK (1) | DK1713458T5 (pt) |
| ES (1) | ES2302177T3 (pt) |
| HU (1) | HUS1500030I1 (pt) |
| LT (1) | LTC1713458I2 (pt) |
| LU (1) | LU92736I2 (pt) |
| MX (1) | MXPA06009274A (pt) |
| NO (2) | NO337656B1 (pt) |
| PL (1) | PL1713458T3 (pt) |
| PT (1) | PT1713458E (pt) |
| RU (1) | RU2385716C2 (pt) |
| WO (1) | WO2005077350A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
| US8642079B2 (en) * | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
| US8758821B2 (en) * | 2004-05-04 | 2014-06-24 | Hormos Medical Ltd. | Oral formulations of ospemifene |
| SI2275098T1 (sl) | 2004-05-04 | 2012-12-31 | Hormos Medical Ltd. | Nove oralne formulacije ospemifena |
| CA2628964A1 (en) * | 2005-11-09 | 2007-09-07 | Hormos Medical Ltd. | Formulations of fispemifene |
| US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| MX2008006885A (es) * | 2005-11-28 | 2008-10-20 | Gtx Inc | Agentes de enlace de receptores nucleares. |
| US8158828B2 (en) * | 2005-11-28 | 2012-04-17 | Gtx, Inc. | Nuclear receptor binding agents |
| US8637706B2 (en) | 2005-11-28 | 2014-01-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US8546451B2 (en) | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| US7504530B2 (en) * | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
| ES2590262T3 (es) * | 2007-02-14 | 2016-11-21 | Hormos Medical Ltd. | Método para la preparación de derivados de trifenilbuteno con valor terapéutico |
| US9427418B2 (en) | 2009-02-23 | 2016-08-30 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| US9624161B2 (en) | 2009-02-23 | 2017-04-18 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| WO2014060639A1 (en) | 2012-10-19 | 2014-04-24 | Fermion Oy | A process for the preparation of ospemifene |
| CN103739456A (zh) * | 2013-12-03 | 2014-04-23 | 镇江圣安医药有限公司 | 2-（对-（（z-4-氯-1,2-二苯基-1-丁烯基）苯氧基）乙醇的新型衍生物及其应用 |
| GR1009542B (el) | 2018-04-25 | 2019-06-07 | Φαρματεν Α.Β.Ε.Ε. | Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων |
| MD3790548T2 (ro) | 2018-05-11 | 2024-02-29 | Xenon Pharmaceuticals Inc | Metode de îmbunătățire a biodisponibilității și expunerii activatorului de canale de potasiu voltaj-dependente |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9207437D0 (en) * | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites |
| GB9418067D0 (en) * | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| GB9604577D0 (en) | 1996-03-04 | 1996-05-01 | Orion Yhtymae Oy | Serum cholesterol lowering agent |
| EP1102755B1 (en) * | 1998-08-07 | 2006-01-04 | Chiron Corporation | Substituted isoxazole derivatives as estrogen receptor modulators |
| US6219674B1 (en) * | 1999-11-24 | 2001-04-17 | Classen Immunotherapies, Inc. | System for creating and managing proprietary product data |
| US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
| US6653639B1 (en) * | 2000-10-17 | 2003-11-25 | Nikon Corporation | Chuck for mounting reticle to a reticle stage |
| AU2002255593A1 (en) | 2001-02-22 | 2002-09-12 | Classen Immunotherapies, Inc. | Improved algorithms and methods for products safety |
| FR2826811B1 (fr) | 2001-06-27 | 2003-11-07 | France Telecom | Procede d'authentification cryptographique |
| UA79797C2 (en) | 2002-06-06 | 2007-07-25 | Hormos Medical Corp | Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| US8236861B2 (en) * | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
| US20050187302A1 (en) * | 2004-02-23 | 2005-08-25 | Hormos Medical Corporation | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
| US8642079B2 (en) * | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
| US8758821B2 (en) * | 2004-05-04 | 2014-06-24 | Hormos Medical Ltd. | Oral formulations of ospemifene |
| US20060293294A1 (en) | 2004-09-03 | 2006-12-28 | Hormos Medical Corporation | Method for treatment or prevention of androgen deficiency |
-
2004
- 2004-02-13 US US10/777,211 patent/US8236861B2/en active Active
-
2005
- 2005-01-14 CN CNA200580004550XA patent/CN1925847A/zh active Pending
- 2005-01-14 JP JP2006552639A patent/JP5577011B2/ja active Active
- 2005-01-14 DK DK05701734T patent/DK1713458T5/da active
- 2005-01-14 CA CA2556089A patent/CA2556089C/en active Active
- 2005-01-14 WO PCT/FI2005/000018 patent/WO2005077350A1/en active IP Right Grant
- 2005-01-14 DE DE602005005165T patent/DE602005005165T2/de active Active
- 2005-01-14 EP EP05701734A patent/EP1713458B1/en active Active
- 2005-01-14 PT PT05701734T patent/PT1713458E/pt unknown
- 2005-01-14 PL PL05701734T patent/PL1713458T3/pl unknown
- 2005-01-14 AT AT05701734T patent/ATE387910T1/de active
- 2005-01-14 MX MXPA06009274A patent/MXPA06009274A/es active IP Right Grant
- 2005-01-14 BR BRPI0507661-7A patent/BRPI0507661A/pt not_active Application Discontinuation
- 2005-01-14 AU AU2005211958A patent/AU2005211958B2/en not_active Ceased
- 2005-01-14 ES ES05701734T patent/ES2302177T3/es active Active
- 2005-01-14 RU RU2006132719/15A patent/RU2385716C2/ru active
-
2006
- 2006-09-05 NO NO20063960A patent/NO337656B1/no unknown
-
2008
- 2008-04-24 CY CY20081100456T patent/CY1111014T1/el unknown
-
2012
- 2012-07-06 US US13/543,166 patent/US8470890B2/en not_active Expired - Lifetime
-
2013
- 2013-05-29 US US13/904,818 patent/US8772353B2/en not_active Expired - Lifetime
-
2014
- 2014-05-12 JP JP2014098549A patent/JP6023119B2/ja active Active
- 2014-06-20 US US14/310,822 patent/US9241915B2/en not_active Expired - Fee Related
-
2015
- 2015-06-10 LU LU92736C patent/LU92736I2/xx unknown
- 2015-06-16 HU HUS1500030C patent/HUS1500030I1/hu unknown
- 2015-06-25 LT LTPA2015023C patent/LTC1713458I2/lt unknown
- 2015-07-08 CY CY2015027C patent/CY2015027I1/el unknown
- 2015-11-25 NO NO20151603A patent/NO339190B1/no unknown
- 2015-12-16 US US14/971,252 patent/US9855224B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU92736I2 (fr) | Ospémifène dans toutes les formes protégées par lebrevet de base | |
| CY1111689T1 (el) | Στερεες φαρμακοτεχνικες μορφες ospemifene | |
| ZA202006378B (en) | N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof | |
| AR051754A1 (es) | Metodos para preparar compuestos de indazol | |
| HRP20150119T1 (hr) | N-supstituirani derivati glicina kao inhibitori hidroksilaze | |
| EA200701745A1 (ru) | Циклопропанкарбоксамидные производные | |
| JP2009507896A5 (pt) | ||
| CY1114892T1 (el) | Φαρμακευτικη συνθεση ενος ισχυρου αναστολεα του hcv για απο του στοματος χορηγηση | |
| RU2009126767A (ru) | Производное 1-фенил-1-тио-d-глюцитола | |
| EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| EA201100994A1 (ru) | Способ получения производных бисфуранового спирта, соединения, соль, фармацевтическая композиция на ее основе, способ лечения или профилактики ретровирусных инфекций с ее помощью | |
| BRPI0617655A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica | |
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| EA022994B1 (ru) | Способ подавления толерантности к опиоидному анальгетику | |
| JP2005536503A5 (pt) | ||
| WO2007099410A3 (en) | Formulations of fispemifene | |
| DK1791537T3 (da) | 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase | |
| DK1678162T3 (da) | P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne | |
| RU2007107850A (ru) | Способы повышения биологической доступности ингибитора ренина | |
| WO2008099781A1 (ja) | アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤 | |
| EA200800776A1 (ru) | Производные хинолина и применение в качестве противоопухолевых агентов | |
| EA200901085A1 (ru) | Производные циклогексиламида арилкарбоновой кислоты | |
| BRPI0510465A (pt) | formulação de droga oral semi-sólida ou lìquida | |
| JP2009046476A5 (pt) |